Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues - Costantini, V; Sidoni, AD; eveglia, R (Cancer, 1996)
et al.